Hyperprolactinaemia in Antipsychotic-Treated Patients

被引：0
作者：
Mark B. Hamner
George W. Arana
机构：
[1] Medical University of South Carolina,Department of Psychiatry and Behavioral Sciences
[2] and the Ralph H. Johnson Department of Veterans Affairs Medical Center,undefined
来源：
CNS Drugs | 1998年 / 10卷
关键词：
Adis International Limited; Haloperidol; Clozapine; Risperidone; Olanzapine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Elevated prolactin (PRL) levels have been considered virtually unavoidable in most patients treated with therapeutic doses of traditional antipsychotics. Clinical effects of such hyperprolactinaemia may include amenorrhoea, galactorrhoea and sexual dysfunction. For clinical symptoms, the management has involved minimising the dosage or the use of a PRL-lowering agent.
引用
收藏
页码：209 / 222
页数：13
相关论文
共 159 条
  • [41] Windgassen K(1997)CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone Neuropsychopharmacology 16 1-7
  • [42] Wesselmann U(1996)Risperidone-induced prolactin elevations in premenopausal women with schizophrenia Neuropsychopharmacology 14 111-23
  • [43] Schulze-Mönking H(1997)Risperidone in the treatment of patients with chronic schizophrenia: a multinational, multicentre, double-blind, parallel-group study versus haloperidol Schizophr Res 26 41-54
  • [44] Wesselmann U(1997)A Canadian multi-center placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients Am J Psychiatry 154 457-65
  • [45] Windgassen J(1993)Risperidone in the treatment of schizophrenia Psychopharmacology 112 285-92
  • [46] Zito JM(1995)Radioreceptor binding profile of the atypical antipsychotic olanzapine Psychopharmacology 119 231-8
  • [47] Sofair JB(1996)A PET study of 5-HT Psychopharmacol Bull 32 107-10
  • [48] Jaeger J(1995) and D Biol Psychiatry 37 683-57
  • [49] Meltzer HY(1997) dopamine receptor occupancy induced by olanzapine in healthy subjects Arch Gen Psychiatry 54 549-46
  • [50] Beaumont PJV(1997)Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial Biol Psychiatry 42 233-33
12345678910